Zentalis Pharmaceuticals, Inc. Investment Income, Interest
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Investment Income, Interest of $99.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2021-11-10
- Zentalis Pharmaceuticals, Inc. investment income, interest for the quarter ending 2021-09-30 was $99.00K, a 17.50% decline year-over-year.
- Zentalis Pharmaceuticals, Inc. investment income, interest for the quarter ending 2021-06-30 was $115.00K, a 36.90% increase year-over-year.
- Zentalis Pharmaceuticals, Inc. investment income, interest for the quarter ending 2021-03-31 was $143.00K, a 12.80% decline year-over-year.
- Zentalis Pharmaceuticals, Inc. investment income, interest for the quarter ending 2020-09-30 was $120.00K, a 900.00% increase year-over-year.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month |
|---|---|---|---|
| 2021-09-30 | $99.00K 10-Q · filed 2021-11-10 | $214.00K derived: sum of 2 quarters · filed 2021-11-10 | $313.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $115.00K 10-Q · filed 2021-08-12 | $214.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $143.00K 10-Q · filed 2021-05-17 | ||
| 2020-09-30 | $120.00K 10-Q · filed 2021-11-10 | $204.00K derived: sum of 2 quarters · filed 2021-11-10 | $368.00K 10-Q · filed 2021-11-10 |
| 2020-06-30 | $84.00K 10-Q · filed 2021-08-12 | $248.00K 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $164.00K 10-Q · filed 2021-05-17 | ||
| 2019-09-30 | $12.00K 10-Q · filed 2020-11-09 | $61.00K derived: sum of 2 quarters · filed 2020-11-09 | $123.00K 10-Q · filed 2020-11-09 |
| 2019-06-30 | $49.00K 10-Q · filed 2020-08-13 | $111.00K 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $74.00K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |